Nutritional Management of Inflammatory Bowel Disease

  • Anthony R. Otley
  • Andrew S. Day
  • Mary ZachosEmail author


Nutritional monitoring and therapy are an integral component of the management of children with inflammatory bowel disease. Given the early age of onset, the impact of the disease can have a profound impact on nutritional status, growth, pubertal development, bone health, self-esteem, and quality of life. In the treatment of IBD in children, nutrition and growth outcomes are critical indicators of overall well-being and therapeutic success in addition to other therapeutic targets of symptom resolution and mucosal healing. In addition to a multitude of pharmacologic approaches to therapy, there is extensive evidence supporting the efficacy of nutritional therapy in Crohn’s disease. Current guidelines support exclusive enteral nutrition (EEN) as the first-line therapy to induce remission in children with active CD. This chapter will focus on nutritional deficiencies and the role of nutritional management in the treatment of IBD.


Pediatric Crohn’s disease Ulcerative colitis Nutritional therapy Diet Exclusive enteral nutrition 


  1. 1.
    Seidman E, LeLeiko N, Ament M, Berman W, Caplan D, Evans J, et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1991;12(4):424–38.PubMedCrossRefGoogle Scholar
  2. 2.
    Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An update of the role of nutritional therapy in the management of Crohn’s disease. J Gastroenterol. 2012;47(8):872–82.PubMedCrossRefGoogle Scholar
  3. 3.
    Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn’s disease. Gastroenterology. 1988;95(6):1523–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis. 2014;8(10):1179–207.PubMedCrossRefGoogle Scholar
  5. 5.
    Levine A, Milo T, Buller H, Markowitz J. Consensus and controversy in the management of pediatric Crohn disease: an international survey. J Pediatr Gastroenterol Nutr. 2003;36(4):464–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, et al. Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. Gut. 2015;64(3):438–46.PubMedCrossRefGoogle Scholar
  7. 7.
    dos Santos GM, Silva LR, Santana GO. Nutritional impact of inflammatory bowel diseases on children and adolescents. Rev Paul Pediatr. 2014;32(4):403–11.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Griffiths A. Inflammatory bowel disease; Chapter 41. In: WADPHJe, editor. Pediatric gastrointestinal disease. 3rd ed. Hamilton: BC Decker; 2000.Google Scholar
  9. 9.
    Jakobsen C, Paerregaard A, Munkholm P, Faerk J, Lange A, Andersen J, et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: a prospective population-based cohort study 2007-2009. Inflamm Bowel Dis. 2011;17(12):2541–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Aurangzeb B, Leach ST, Lemberg DA, Day AS. Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;52(5):536–41.PubMedCrossRefGoogle Scholar
  11. 11.
    Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007;151(5):523–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Kelts DG, Grand RJ, Shen G, Watkins JB, Werlin SL, Boehme C. Nutritional basis of growth failure in children and adolescents with Crohn’s disease. Gastroenterology. 1979;76(4):720–7.PubMedGoogle Scholar
  13. 13.
    Kirschner BS, Klich JR, Kalman SS, deFavaro MV, Rosenberg IH. Reversal of growth retardation in Crohn’s disease with therapy emphasizing oral nutritional restitution. Gastroenterology. 1981;80(1):10–5.PubMedGoogle Scholar
  14. 14.
    Kirschner BS, Voinchet O, Rosenberg IH. Growth retardation in inflammatory bowel disease. Gastroenterology. 1978;75(3):504–11.PubMedGoogle Scholar
  15. 15.
    Motil KJ, Altchuler SI, Grand RJ. Mineral balance during nutritional supplementation in adolescents with Crohn disease and growth failure. J Pediatr. 1985;107(3):473–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Motil KJ, Grand RJ, Maletskos CJ, Young VR. The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure. J Pediatr. 1982;101(3):345–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn’s disease. J Pediatr Gastroenterol Nutr. 1993;17(1):75–81.PubMedCrossRefGoogle Scholar
  18. 18.
    Shamir R, Philip M, Levine A. Growth retardation in pediatric Crohn’s disease: pathogenesis and interventions. Inflamm Bowel Dis. 2001;13:620–8.CrossRefGoogle Scholar
  19. 19.
    Kleinman RE, Baldassano RN, Caplan A, Griffiths AM, Heyman MB, Issenman RM, et al. Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology And Nutrition. J Pediatr Gastroenterol Nutr. 2004;39(1):15–27.PubMedCrossRefGoogle Scholar
  20. 20.
    Thayu M, Denson LA, Shults J, Zemel BS, Burnham JM, Baldassano RN, et al. Determinants of changes in linear growth and body composition in incident pediatric Crohn’s disease. Gastroenterology. 2010;139(2):430–8.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Pons R, Whitten KE, Woodhead H, Leach ST, Lemberg DA, Day AS. Dietary intakes of children with Crohn’s disease. Br J Nutr. 2009;102(7):1052–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Costa CO, Carrilho FJ, Nunes VS, Sipahi AM, Rodrigues M. A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study. BMC Gastroenterol. 2015;15:172.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Thangarajah D, Hyde MJ, Konteti VK, Santhakumaran S, Frost G, Fell JM. Systematic review: body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42(2):142–57.PubMedCrossRefGoogle Scholar
  24. 24.
    Burnham JM, Shults J, Semeao E, Foster BJ, Zemel BS, Stallings VA, et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr. 2005;82(2):413–20.PubMedGoogle Scholar
  25. 25.
    Azcue M, Rashid M, Griffiths A, Pencharz PB. Energy expenditure and body composition in children with Crohn’s disease: effect of enteral nutrition and treatment with prednisolone. Gut. 1997;41(2):203–8.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Wiskin AE, Wootton SA, Hunt TM, Cornelius VR, Afzal NA, Jackson AA, et al. Body composition in childhood inflammatory bowel disease. Clin Nutr (Edinburgh, Scotland).Google Scholar
  27. 27.
    Thayu M, Shults J, Burnham JM, Zemel BS, Baldassano RN, Leonard MB. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn’s disease. Inflamm Bowel Dis. 2007;13(9):1121–8.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42(2):188–94.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Sylvester FA, Leopold S, Lincoln M, Hyams JS, Griffiths AM, Lerer T. A two-year longitudinal study of persistent lean tissue deficits in children with Crohn’s disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2009;7(4):452–5.Google Scholar
  30. 30.
    Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996;335(25):1897–905.PubMedCrossRefGoogle Scholar
  31. 31.
    Zoli G, Care M, Falco F, Parazza M, Spano CG. Effect of oral elemental diet on nutritional status, intestinal permeability and disease activity in Crohn’s patients. Gastroenterology. 1996;110(4):A1054.Google Scholar
  32. 32.
    Varille V, Cezard JP, de Lagausie P, Bellaiche M, Tounian P, Besnard M, et al. Resting energy expenditure before and after surgical resection of gut lesions in pediatric Crohn’s disease. J Pediatr Gastroenterol Nutr. 1996;23(1):13–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis. 2012;6(6):665–73.PubMedCrossRefGoogle Scholar
  34. 34.
    Nguyen T, Ploeger HE, Obeid J, Issenman RM, Baker JM, Takken T, et al. Reduced fat oxidation rates during submaximal exercise in adolescents with Crohn’s disease. Inflamm Bowel Dis. 2013;19(12):2659–65.PubMedCrossRefGoogle Scholar
  35. 35.
    Li Y, Zhu W. Body fat composition predicts infectious complications after bowel resection in Crohn’s disease. Inflamm Bowel Dis. 2015;21(8):E19.PubMedCrossRefGoogle Scholar
  36. 36.
    Bryant RV, Ooi S, Schultz CG, Goess C, Grafton R, Hughes J, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(9):895–906.PubMedCrossRefGoogle Scholar
  37. 37.
    Hannon TS, Dimeglio LA, Pfefferkorn MD, Denne SC. Acute effects of enteral nutrition on protein turnover in adolescents with Crohn disease. Pediatr Res. 2007;61(3):356–60.PubMedCrossRefGoogle Scholar
  38. 38.
    Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012;18(10):1961–81.PubMedCrossRefGoogle Scholar
  39. 39.
    Levin AD, Wadhera V, Leach ST, Woodhead HJ, Lemberg DA, Mendoza-Cruz AC, et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci. 2011;56(3):830–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Yakut M, Ustun Y, Kabacam G, Soykan I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med. 2010;21(4):320–3.PubMedCrossRefGoogle Scholar
  41. 41.
    Alkhouri RH, Hashmi H, Baker RD, Gelfond D, Baker SS. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;56(1):89–92.PubMedCrossRefGoogle Scholar
  42. 42.
    Trebble TM, Wootton SA, May A, Erlewyn-Lajeunesse MD, Chakraborty A, Mullee MA, et al. Essential fatty acid status in paediatric Crohn’s disease: relationship with disease activity and nutritional status. Aliment Pharmacol Ther. 2003;18(4):433–42.PubMedCrossRefGoogle Scholar
  43. 43.
    Driscoll Jr RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. 1982;83(6):1252–8.PubMedGoogle Scholar
  44. 44.
    Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998;67(5):919–26.PubMedGoogle Scholar
  45. 45.
    Gerasimidis K, Talwar D, Duncan A, Moyes P, Buchanan E, Hassan K, et al. Impact of exclusive enteral nutrition on body composition and circulating micronutrients in plasma and erythrocytes of children with active Crohn’s disease. Inflamm Bowel Dis. 2012;18(9):1672–81.PubMedCrossRefGoogle Scholar
  46. 46.
    Gerasimidis K, Barclay A, Papangelou A, Missiou D, Buchanan E, Tracey C, et al. The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm Bowel Dis. 2013;19(11):2411–22.PubMedCrossRefGoogle Scholar
  47. 47.
    Van Gossum A, Cabre E, Hebuterne X, Jeppesen P, Krznaric Z, Messing B, et al. ESPEN guidelines on parenteral nutrition: gastroenterology. Clin Nutr (Edinburgh, Scotland). 2009;28(4):415–27.CrossRefGoogle Scholar
  48. 48.
    Kleinman RE, Balistreri WF, Heyman MB, Kirschner BS, Lake AM, Motil KJ, et al. Nutritional support for pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1989;8(1):8–12.PubMedCrossRefGoogle Scholar
  49. 49.
    Kitney L, Turner JM, Spady D, Malik B, El-Matary W, Persad R, et al. Predictors of medication adherence in pediatric inflammatory bowel disease patients at the Stollery Children’s Hospital. Can J Gastroenterol. 2009;23(12):811–5.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Greenley RN, Stephens KA, Nguyen EU, Kunz JH, Janas L, Goday P, et al. Vitamin and mineral supplement adherence in pediatric inflammatory bowel disease. J Pediatr Psychol. 2013;38(8):883–92.PubMedCrossRefGoogle Scholar
  51. 51.
    Sondike S. Weight status in pediatric IBD patients at the time of diagnosis: effects of the obesity epidemic. J Pediatr Gastroenterol Nutr. 2004;39(Suppl 1):S317.CrossRefGoogle Scholar
  52. 52.
    Long MD, Crandall WV, Leibowitz IH, Duffy L, del Rosario F, Kim SC, et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(10):2162–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Chan SS, Luben R, Olsen A, Tjonneland A, Kaaks R, Teucher B, et al. Body mass index and the risk for Crohn’s disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol. 2013;108(4):575–82.PubMedCrossRefGoogle Scholar
  54. 54.
    Teahon K, Pearson M, Smith T, Bjarnason I. Alterations in nutritional status and disease activity during treatment of Crohn’s disease with elemental diet. Scand J Gastroenterol. 1995;30(1):54–60.PubMedCrossRefGoogle Scholar
  55. 55.
    Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81(11):3861–3.PubMedGoogle Scholar
  56. 56.
    Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, Caro JF. Serum leptin in children with obesity: relationship to gender and development. Pediatrics. 1996;98(2 Pt 1):201–3.PubMedGoogle Scholar
  57. 57.
    Singhal A, Farooqi IS, O’Rahilly S, Cole TJ, Fewtrell M, Lucas A. Early nutrition and leptin concentrations in later life. Am J Clin Nutr. 2002;75(6):993–9.PubMedGoogle Scholar
  58. 58.
    Soliman AT, ElZalabany MM, Salama M, Ansari BM. Serum leptin concentrations during severe protein-energy malnutrition: correlation with growth parameters and endocrine function. Metab Clin Exp. 2000;49(7):819–25.PubMedCrossRefGoogle Scholar
  59. 59.
    Hoppin AG, Kaplan LM, Zurakowski D, Leichtner AM, Bousvaros A. Serum leptin in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1998;26(5):500–5.PubMedCrossRefGoogle Scholar
  60. 60.
    Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998;114(5):902–11.PubMedCrossRefGoogle Scholar
  61. 61.
    Compston JE. Management of bone disease in patients on long term glucocorticoid therapy. Gut. 1999;44(6):770–2.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Hyams JS, Carey DE. Corticosteroids and growth. J Pediatr. 1988;113(2):249–54.PubMedCrossRefGoogle Scholar
  63. 63.
    Franklin JL, Rosenberg HH. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology. 1973;64(4):517–25.PubMedGoogle Scholar
  64. 64.
    Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, et al. Methotrexate for the treatment of Crohn’s disease. The North American Crohn’s Study Group Investigators. N Engl J Med. 1995;332(5):292–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Brown AC, Rampertab SD, Mullin GE. Existing dietary guidelines for Crohn’s disease and ulcerative colitis. Exp Rev Gastroenterol Hepatol. 2011;5(3):411–25.CrossRefGoogle Scholar
  66. 66.
    Wedrychowicz A, Kowalska-Duplaga K, Jedynak-Wasowicz U, Pieczarkowski S, Sladek M, Tomasik P, et al. Serum concentrations of VEGF and TGF-beta1 during exclusive enteral nutrition in IBD. J Pediatr Gastroenterol Nutr. 2011;53(2):150–5.PubMedCrossRefGoogle Scholar
  67. 67.
    Voitk AJ, Echave V, Feller JH, Brown RA, Gurd FN. Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg. 1973;107(2):329–33.PubMedCrossRefGoogle Scholar
  68. 68.
    O’Morain CA, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. Br Med J (Clin Res Ed). 1984;288(6434):1859–62.CrossRefGoogle Scholar
  69. 69.
    Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn’s disease. Arch Dis Child. 1987;62(2):123–7.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, et al. Enteral nutrition and microflora in pediatric Crohn’s disease. JPEN J Parenter Enteral Nutr. 2005;29(4 Suppl):S173–5. discussion S5-8, S84-8.PubMedCrossRefGoogle Scholar
  71. 71.
    Pryce-Millar E, Murch SH, Heuschkel RB. Enteral nutrition therapy in Crohn’s disease changes the mucosal flora [abstract]. JPGN J Pediatr Gastroenterol Nutr. 2004;39(Suppl 1):289.CrossRefGoogle Scholar
  72. 72.
    Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn’s disease. Aliment Pharmacol Ther. 2008;28(6):724–33.PubMedCrossRefGoogle Scholar
  73. 73.
    Kaakoush NO, Day AS, Leach ST, Lemberg DA, Nielsen S, Mitchell HM. Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn’s disease. Clin Trans Gastroenterol. 2015;6:e71.CrossRefGoogle Scholar
  74. 74.
    Quince C, Ijaz UZ, Loman N, Eren AM, Saulnier D, Russell J, et al. Extensive modulation of the fecal metagenome in children with Crohn’s disease during exclusive enteral nutrition. Am J Gastroenterol. 2015;110(12):1718–29. quiz 30.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Lewis JD, Chen EZ, Baldassano RN, Otley AR, Griffiths AM, Lee D, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe. 2015;18(4):489–500.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Kajiura T, Takeda T, Sakata S, Sakamoto M, Hashimoto M, Suzuki H, et al. Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis. Dig Dis Sci. 2009;54(9):1892–900.PubMedCrossRefGoogle Scholar
  77. 77.
    Smith AR, Macfarlane S, Furrie E, Ahmed S, Bahrami B, Reynolds N, et al. Microbiological and immunological effects of enteral feeding on the upper gastrointestinal tract. J Med Microbiol. 2011;60(Pt 3):359–65.PubMedCrossRefGoogle Scholar
  78. 78.
    Whelan K, Judd PA, Tuohy KM, Gibson GR, Preedy VR, Taylor MA. Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am J Clin Nutr. 2009;89(1):240–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Meister D, Bode J, Shand A, Ghosh S. Anti-inflammatory effects of enteral diet components on Crohn’s disease-affected tissues in vitro. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2002;34(6):430–8.Google Scholar
  80. 80.
    de Jong NS, Leach ST, Day AS. Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig Dis Sci. 2007;52(9):2029–36.PubMedCrossRefGoogle Scholar
  81. 81.
    Nahidi L, Corley SM, Wilkins MR, Wei J, Alhagamhmad M, Day AS, et al. The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis. Genes Nutr. 2015;10(5):479.PubMedCrossRefGoogle Scholar
  82. 82.
    Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. Exploring and enhancing the anti-inflammatory properties of polymeric formula. JPEN J Parenter Enteral Nutrition. 2016. PMID: 26826259. [Epub ahead of print].Google Scholar
  83. 83.
    Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn’s disease. Scand J Gastroenterol. 1992;27(9):721–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Teahon K, Smethurst P, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in patients with Crohn’s disease and their first degree relatives. Gut. 1992;33(3):320–3.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am J Gastroenterol. 2002;97(8):2000–4.PubMedCrossRefGoogle Scholar
  86. 86.
    Guzy C, Schirbel A, Paclik D, Wiedenmann B, Dignass A, Sturm A. Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro. Eur J Nutr. 2009;48(1):12–21.PubMedCrossRefGoogle Scholar
  87. 87.
    Nahidi L, Day AS, Lemberg DA, Leach ST. Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model. J Gastroenterol. 2011;47(2):107–17.PubMedCrossRefGoogle Scholar
  88. 88.
    Nahidi L, Leach ST, Mitchell HM, Kaakoush NO, Lemberg DA, Munday JS, et al. Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int. 2013;2013:909613.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Narula N, Tondeur M, Sherlock M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn’s disease. Update. Cochrane Database Syst Rev. 2015;CD000542.Google Scholar
  90. 90.
    Grogan JL, Casson DH, Terry A, Burdge GC, El-Matary W, Dalzell AM. Enteral feeding therapy for newly diagnosed pediatric Crohn’s disease: a double-blind randomized controlled trial with two years follow-up. Inflamm Bowel Dis. 2012;18(2):246–53.PubMedCrossRefGoogle Scholar
  91. 91.
    Gorard DA, Hunt JB, Payne-James JJ, Palmer KR, Rees RG, Clark ML, et al. Initial response and subsequent course of Crohn’s disease treated with elemental diet or prednisolone. Gut. 1993;34(9):1198–202.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Lindor KD, Fleming CR, Burnes JU, Nelson JK, Ilstrup DM. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn’s disease. Mayo Clin Proc. 1992;67(4):328–33.PubMedCrossRefGoogle Scholar
  93. 93.
    Lochs H, Steinhardt HJ, Klaus-Wentz B, Zeitz M, Vogelsang H, Sommer H, et al. Comparison of enteral nutrition and drug treatment in active Crohn’s disease. Results of the European Cooperative Crohn’s Disease Study. IV. Gastroenterology. 1991;101(4):881–8.PubMedCrossRefGoogle Scholar
  94. 94.
    Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, et al. European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984;86(2):249–66.PubMedGoogle Scholar
  95. 95.
    Seidman EG, Griffiths AM, Jones A, Issenman R. Semi-elemental diet versus prednisone in pediatric Crohn’s disease. Gastroenterology. 1993;104:A778.Google Scholar
  96. 96.
    Seidman EG, Lohoues MJ, Turgeon J, Bouthillier L, Morin CL. Elemental diet versus prednisone as initial therapy i Crohn’s disease: early and long-term results. Gastroenterology. 1991;100:150A.CrossRefGoogle Scholar
  97. 97.
    Levine A, Turner D, Pfeffer Gik T, Amil Dias J, Veres G, Shaoul R, et al. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn’s disease: evaluation of the porto IBD group “growth relapse and outcomes with therapy” (GROWTH CD) study. Inflamm Bowel Dis. 2014;20(2):278–85.PubMedCrossRefGoogle Scholar
  98. 98.
    Fernandez-Banares F, Cabre E, Esteve-Copmans M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn’s disease? A meta-analysis of the randomized clinical trials. J Parenter Enter Nutr. 1995;19:1056–64.CrossRefGoogle Scholar
  99. 99.
    Messori A, Trallori G, D’Albrasio G, Milla M, Vanozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn’s disease. A Meta-Analysis. Scand J Gastroenterol. 1996;31:267–72.PubMedCrossRefGoogle Scholar
  100. 100.
    Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007(1):CD000542.Google Scholar
  101. 101.
    Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, et al. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn’s disease. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2006;38(6):381–7.Google Scholar
  102. 102.
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.PubMedCrossRefGoogle Scholar
  103. 103.
    Gonzalez-Huix F, de Leon R, Fernandez-Banares F, Esteve M, Cabre E, Acero D, et al. Polymeric enteral diets as primary treatment of active Crohn’s disease: a prospective steroid controlled trial. Gut. 1993;34(6):778–82.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr. 2000;31(1):8–15.PubMedCrossRefGoogle Scholar
  105. 105.
    Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, et al. Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol. 2006;21(10):1609–14.PubMedCrossRefGoogle Scholar
  106. 106.
    Otley A, Grant A, Giffin N, Mahdi G, Rashid M, Van Limbergen J. Steroids no more! Exclusive Enteral nutrition therapy in pediatric patients with Crohn’s disease results in long term avoidance of corticosteroid therapy. J Crohns Colitis. 2015;9(Supplement 1):S393.Google Scholar
  107. 107.
    Luo Y, Yu J, Zhao H, Lou J, Chen F, Peng K, et al. Short-term efficacy of exclusive enteral nutrition in pediatric Crohn’s disease: practice in China. Gastroenterol Res Pract. 2015;2015:428354.PubMedPubMedCentralGoogle Scholar
  108. 108.
    Soo J, Malik BA, Turner JM, Persad R, Wine E, Siminoski K, et al. Use of exclusive enteral nutrition is just as effective as corticosteroids in newly diagnosed pediatric Crohn’s disease. Dig Dis Sci. 2013;58(12):3584–91.PubMedCrossRefGoogle Scholar
  109. 109.
    Lee D, Baldassano RN, Otley AR, Albenberg L, Griffiths AM, Compher C, et al. Comparative effectiveness of nutritional and biological therapy in North American children with active Crohn’s disease. Inflamm Bowel Dis. 2015;21(8):1786–93.PubMedCrossRefGoogle Scholar
  110. 110.
    Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007;3:CD005984.Google Scholar
  111. 111.
    Verma S, Holdsworth CD, Giaffer MH. Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scand J Gastroenterol. 2001;36(4):383–8.PubMedCrossRefGoogle Scholar
  112. 112.
    Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Iwabuchi M, et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24(9):1333–40.PubMedCrossRefGoogle Scholar
  113. 113.
    Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K. Enteral nutrition for the maintenance of remission in Crohn’s disease: a systematic review. Eur J Gastroenterol Hepatol. 2010;22(1):1–8.PubMedCrossRefGoogle Scholar
  114. 114.
    Verma S, Kirkwood B, Brown S, Giaffer MH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn’s disease. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2000;32(9):769–74.Google Scholar
  115. 115.
    Yamamoto T, Nakahigashi M, Saniabadi AR, Iwata T, Maruyama Y, Umegae S, et al. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study. Inflamm Bowel Dis. 2007;13(12):1493–501.PubMedCrossRefGoogle Scholar
  116. 116.
    Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007;25(1):67–72.PubMedCrossRefGoogle Scholar
  117. 117.
    Hirakawa H, Fukuda Y, Tanida N, Hosomi M, Shimoyama T. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn’s disease. Gastroenterol Jpn. 1993;28(3):379–84.PubMedGoogle Scholar
  118. 118.
    Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn’s disease. Gut. 1996;38(4):543–8.PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Esaki M, Matsumoto T, Nakamura S, Yada S, Fujisawa K, Jo Y, et al. Factors affecting recurrence in patients with Crohn’s disease under nutritional therapy. Dis Colon Rectum. 2006;49(10 Suppl):S68–74.PubMedCrossRefGoogle Scholar
  120. 120.
    Ikeuchi H, Yamamura T, Nakano H, Kosaka T, Shimoyama T, Fukuda Y. Efficacy of nutritional therapy for perforating and non-perforating Crohn’s disease. Hepato-Gastroenterology. 2004;51(58):1050–2.PubMedGoogle Scholar
  121. 121.
    Esaki M, Matsumoto T, Hizawa K, Nakamura S, Jo Y, Mibu R, et al. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand J Gastroenterol. 2005;40(12):1431–7.PubMedCrossRefGoogle Scholar
  122. 122.
    Bamba T, Shimoyama T, Sasaki M, Tsujikawa T, Fukuda Y, Koganei K, et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn’s disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol. 2003;15(2):151–7.PubMedCrossRefGoogle Scholar
  123. 123.
    Belli DC, Seidman E, Bouthillier L, Weber AM, Roy CC, Pletincx M, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn’s disease. Gastroenterology. 1988;94(3):603–10.PubMedCrossRefGoogle Scholar
  124. 124.
    Nguyen DL, Palmer LB, Nguyen ET, McClave SA, Martindale RG, Bechtold ML. Specialized enteral nutrition therapy in Crohn’s disease patients on maintenance infliximab therapy: a meta-analysis. Ther Adv Gastroenterol. 2015;8(4):168–75.CrossRefGoogle Scholar
  125. 125.
    Buchanan E, Gaunt WW, Cardigan T, Garrick V, McGrogan P, Russell RK. The use of exclusive enteral nutrition for induction of remission in children with Crohn’s disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther. 2009;30(5):501–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Grover Z, Lewindon P. Two-year outcomes after exclusive enteral nutrition induction are superior to corticosteroids in pediatric Crohn’s disease treated early with thiopurines. Dig Dis Sci. 2015;60(10):3069–74.PubMedCrossRefGoogle Scholar
  127. 127.
    Kang Y, Kim S, Kim SY, Koh H. Effect of short-term partial enteral nutrition on the treatment of younger patients with severe Crohn’s disease. Gut Liver. 2015;9(1):87–93.PubMedCrossRefGoogle Scholar
  128. 128.
    Frivolt K, Schwerd T, Werkstetter KJ, Schwarzer A, Schatz SB, Bufler P, et al. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn’s disease: predictors of efficacy and outcome. Aliment Pharmacol Ther. 2014;39(12):1398–407.PubMedCrossRefGoogle Scholar
  129. 129.
    Knight C, El-Matary W, Spray C, Sandhu BK. Long-term outcome of nutritional therapy in paediatric Crohn’s disease. Clin Nutr (Edinburgh, Scotland). 2005;24(5):775–9.CrossRefGoogle Scholar
  130. 130.
    Cameron FL, Gerasimidis K, Papangelou A, Missiou D, Garrick V, Cardigan T, et al. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn’s disease. Aliment Pharmacol Ther. 2013;37(6):622–9.PubMedCrossRefGoogle Scholar
  131. 131.
    Lambert B, Lemberg DA, Leach ST, Day AS. Longer-term outcomes of nutritional management of Crohn’s disease in children. Dig Dis Sci. 2012;57(8):2171–7.PubMedCrossRefGoogle Scholar
  132. 132.
    Froslie KF, Jahnsen J, Moum BA, Vatn MH, Group I. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133(2):412–22.PubMedCrossRefGoogle Scholar
  133. 133.
    Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119(1):15–22.PubMedCrossRefGoogle Scholar
  134. 134.
    Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, et al. Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution on prednisolone. Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology. 1990;98(4):811–8.PubMedCrossRefGoogle Scholar
  135. 135.
    Fell JME, Paintin M, Arnaud-Battandier F, Beatties RM, Hollis A, Kitching P, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharmacol Ther. 2000;14:281–9.PubMedCrossRefGoogle Scholar
  136. 136.
    Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2006;4(6):744–53.Google Scholar
  137. 137.
    Grover Z, Muir R, Lewindon P. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn’s disease. J Gastroenterol. 2014;49(4):638–45.PubMedCrossRefGoogle Scholar
  138. 138.
    Grover Z, Burgess C, Muir R, Reilly C, Lewindon PJ. Early mucosal healing with exclusive enteral nutrition is associated with improved outcomes in newly diagnosed children with luminal Crohn’s disease. J Crohns Colitis. 2016;10(10):1159–64.PubMedCrossRefGoogle Scholar
  139. 139.
    Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn’s disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis. 2005;11(6):580–8.PubMedCrossRefGoogle Scholar
  140. 140.
    Breese EJ, Michie CA, Nicholls SW, Williams CB, Domizio P, Walker-Smith JA, et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease. Aliment Pharmacol Ther. 1995;9(5):547–52.PubMedCrossRefGoogle Scholar
  141. 141.
    Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology. 1994;106(6):1455–66.PubMedCrossRefGoogle Scholar
  142. 142.
    Ferguson A, Glen M, Ghosh S. Crohn’s disease: nutrition and nutritional therapy. Baillieres Clin Gastroenterol. 1998;12(1):93–114.PubMedCrossRefGoogle Scholar
  143. 143.
    Judd TA, Day AS, Lemberg DA, Turner D, Leach ST. Update of fecal markers of inflammation in inflammatory bowel disease. J Gastroenterol Hepatol. 2011;26(10):1493–9.PubMedCrossRefGoogle Scholar
  144. 144.
    Gerasimidis K, Nikolaou CK, Edwards CA, McGrogan P. Serial fecal calprotectin changes in children with Crohn’s disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse. J Clin Gastroenterol. 2011;45(3):234–9.PubMedCrossRefGoogle Scholar
  145. 145.
    de Jong NS, Leach ST, Day AS. Fecal S100A12: a novel noninvasive marker in children with Crohn’s disease. Inflamm Bowel Dis. 2006;12(7):566–72.PubMedCrossRefGoogle Scholar
  146. 146.
    Nahidi L, Leach ST, Sidler MA, Levin A, Lemberg DA, Day AS. Osteoprotegerin in pediatric Crohn’s disease and the effects of exclusive enteral nutrition. Inflamm Bowel Dis. 2011;17(2):516–23.PubMedCrossRefGoogle Scholar
  147. 147.
    Bannerjee K, Camacho-Hubner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr. 2004;38(3):270–5.PubMedCrossRefGoogle Scholar
  148. 148.
    Beattie RM, Camacho-Hubner C, Wacharasindhu S, Cotterill AM, Walker-Smith JA, Savage MO. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn’s disease. Clin Endocrinol. 1998;49(4):483–9.CrossRefGoogle Scholar
  149. 149.
    Royall D, Greenberg GR, Allard JP, Baker JP, Jeejeebhoy KN. Total enteral nutrition support improves body composition of patients with active Crohn’s disease. JPEN J Parenter Enteral Nutr. 1995;19(2):95–9.PubMedCrossRefGoogle Scholar
  150. 150.
    Afzal NA, Davies S, Paintin M, Arnaud-Battandier F, Walker-Smith JA, Murch S, et al. Colonic Crohn’s disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci. 2005;50(8):1471–5.PubMedCrossRefGoogle Scholar
  151. 151.
    Newby EA, Sawczenko A, Thomas AG, Wilson D. Interventions for growth failure in childhood Crohn’s disease. Cochrane Database Syst Rev. 2005;3:CD003873.Google Scholar
  152. 152.
    Whitten KE, Leach ST, Bohane TD, Woodhead HJ, Day AS. Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease. J Gastroenterol. 2010;45(4):399–405.PubMedCrossRefGoogle Scholar
  153. 153.
    Werkstetter KJ, Schatz SB, Alberer M, Filipiak-Pittroff B, Koletzko S. Influence of exclusive enteral nutrition therapy on bone density and geometry in newly diagnosed pediatric Crohn’s disease patients. Ann Nutr Metab. 2013;63(1–2):10–6.PubMedCrossRefGoogle Scholar
  154. 154.
    Otley A, Smith C, Nicholas D, Munk M, Avolio J, Sherman PM, et al. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;35(4):557–63.PubMedCrossRefGoogle Scholar
  155. 155.
    Gailhoustet L, Goulet O, Cachin N, Schmitz J. Study of psychological repercussions of 2 modes of treatment of adolescents with Crohn’s disease. Arch Pediatr. 2002;9(2):110–6.PubMedCrossRefGoogle Scholar
  156. 156.
    Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, et al. Improvement in quality of life of children with acute Crohn’s disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther. 2004;20(2):167–72.PubMedCrossRefGoogle Scholar
  157. 157.
    Hill R, Lewindon P, Muir R, Grange I, Connor F, Ee L, et al. Quality of life in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2010;51(1):35–40.PubMedCrossRefGoogle Scholar
  158. 158.
    Kuriyama M, Kato J, Morimoto N, Fujimoto T, Kono H, Okano N, et al. Enteral nutrition improves health-related quality of life in Crohn’s disease patients with long disease duration. Hepato-Gastroenterology. 2009;56(90):321–7.PubMedGoogle Scholar
  159. 159.
    Li G, Ren J, Wang G, Hu D, Gu G, Liu S, et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. Eur J Clin Nutr. 2014;68(4):441–6.PubMedCrossRefGoogle Scholar
  160. 160.
    Li Y, Zuo L, Zhu W, Gong J, Zhang W, Gu L, et al. Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn’s disease following immunosuppressive therapy. Medicine. 2015;94(5):e478.PubMedPubMedCentralCrossRefGoogle Scholar
  161. 161.
    Kuroki F, Matsumoto T, Iida M. Selenium is depleted in Crohn’s disease on enteral nutrition. Dig Dis. 2003;21(3):266–70.PubMedCrossRefGoogle Scholar
  162. 162.
    Akobeng AK, Richmond K, Miller V, Thomas AG. Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn’s disease. Clin Nutr (Edinburgh, Scotland). 2007;26(1):51–6.CrossRefGoogle Scholar
  163. 163.
    Gerasimidis K, Talwar D, Duncan A, Moyes P, Buchanan E, Hassan K, et al. Impact of exclusive enteral nutrition on body composition and circulating micronutrients in plasma and erythrocytes of children with active Crohn’s disease. Inflamm Bowel Dis. 2011;18(9):1672–81.PubMedCrossRefGoogle Scholar
  164. 164.
    Schatorje E, Hoekstra H. Transient hypertransaminasemia in paediatric patients with Crohn disease undergoing initial treatment with enteral nutrition. J Pediatr Gastroenterol Nutr. 2010;51(3):336–40.PubMedGoogle Scholar
  165. 165.
    Lemberg DA, Leach ST, Day AS. Transient hypertransaminasemia in pediatric patients with Crohn disease. J Pediatr Gastroenterol Nutr. 2011;53(2):229.PubMedCrossRefGoogle Scholar
  166. 166.
    Afzal NA, Addai S, Fagbemi A, Murch S, Thomson M, Heuschkel R. Refeeding syndrome with enteral nutrition in children: a case report, literature review and clinical guidelines. Clin Nutr (Edinburgh, Scotland). 2002;21(6):515–20.CrossRefGoogle Scholar
  167. 167.
    Akobeng AK, Thomas AG. Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease. J Pediatr Gastroenterol Nutr. 2010;51(3):364–6.PubMedGoogle Scholar
  168. 168.
    Seidman E. Relapse prevention/growth enhancement in pediatric Crohn’s disease: multicentre randomized controlled trial of intermittent enteral nutrition versus alternate day prednisone. J Pediatr Gastroenterol Nutr. 1996;23:A344.CrossRefGoogle Scholar
  169. 169.
    Rubio A, Pigneur B, Garnier-Lengline H, Talbotec C, Schmitz J, Canioni D, et al. The efficacy of exclusive nutritional therapy in paediatric Crohn’s disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther. 2011;33(12):1332–9.PubMedCrossRefGoogle Scholar
  170. 170.
    Beattie RM, Schiffrin EJ, Donnet-Hughes A, Huggett AC, Domizio P, MacDonald TT, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn’s disease. Aliment Pharmacol Ther. 1994;8(6):609–15.PubMedCrossRefGoogle Scholar
  171. 171.
    O’Sullivan MA, O’Morain CA. Nutritional therapy in Crohn’s disease. Inflamm Bowel Dis. 1998;4(1):45–53.PubMedCrossRefGoogle Scholar
  172. 172.
    Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn’s disease. J Pediatr Gastroenterol Nutr. 2000;30(1):78–84.PubMedCrossRefGoogle Scholar
  173. 173.
    Gassull MA, Fernandez-Banares F, Cabre E, Papo M, Giaffer MH, Sanchez-Lombrana JL, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn’s disease: results of a double blind randomised multicentre european trial. Gut. 2002;51(2):164–8.PubMedPubMedCentralCrossRefGoogle Scholar
  174. 174.
    Leiper K, Woolner J, Mullan MM, Parker T, van der Vliet M, Fear S, et al. A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn’s disease. Gut. 2001;49(6):790–4.PubMedPubMedCentralCrossRefGoogle Scholar
  175. 175.
    Sakurai T, Matsui T, Yao T, Takagi Y, Hirai F, Aoyagi K, et al. Short-term efficacy of enteral nutrition in the treatment of active crohn’s disease: a randomized, controlled trial comparing nutrient formulas. J Parenter Enteral Nutr. 2002;26(2):98–103.CrossRefGoogle Scholar
  176. 176.
    Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut. 2006;55(3):356–61.PubMedPubMedCentralCrossRefGoogle Scholar
  177. 177.
    Gupta K, Noble AJ, Baldassano RN, Sreedharan R, Grossman AB. A novel enteral nutritional therapy protocol for the treatment of pediatric Crohn’s disease. JPGN J Pediatr Gastroenterol Nutr. 2010;51(Suppl 2):E87.Google Scholar
  178. 178.
    Whitten KE, Rogers P, Ooi CK, Day AS. International survey of enteral nutrition protocols used in children with Crohn’s disease. J Dig Dis. 2012;13(2):107–12.PubMedCrossRefGoogle Scholar
  179. 179.
    Otley A, Murray A, Crhistensen B, Williams T, Rashid M, Ste-Marie M. Primary enteral nutrition induces and maintains remission and reduces steroid exposure in a paediatric Crohn’s disease population. Gastroenterology. 2005;128(4(Suppl 2)):W1053.Google Scholar
  180. 180.
    Riordan AM, Hunter JO, Cowan RE, Crampton JR, Davidson AR, Dickinson RJ, et al. Treatment of active Crohn’s disease by exclusion diet: East Anglian multicentre controlled trial. Lancet. 1993;342(8880):1131–4.PubMedCrossRefGoogle Scholar
  181. 181.
    Shergill-Bonner R, Brennan M, Torrente F, Heuschkel R. Food reintroduction after exclusive enteral nutrition – a clinical experience. JPGN J Pediatr Gastroenterol Nutr. 2007;44:E36.Google Scholar
  182. 182.
    Faiman A, Mutalib M, Moylan A, Morgan N, Crespi D, Furman M, et al. Standard versus rapid food reintroduction after exclusive enteral nutritional therapy in paediatric Crohn’s disease. Eur J Gastroenterol Hepatol. 2014;26(3):276–81.PubMedCrossRefGoogle Scholar
  183. 183.
    Konno M, Kobayashi A, Tomomasa T, Kaneko H, Toyoda S, Nakazato Y, et al. Guidelines for the treatment of Crohn’s disease in children. Pediatr Int. 2006;48(3):349–52.PubMedCrossRefGoogle Scholar
  184. 184.
    Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schutz T, et al. ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr (Edinburgh, Scotland). 2006;25(2):260–74.CrossRefGoogle Scholar
  185. 185.
    Grafors JM, Casswall TH. Exclusive enteral nutrition in the treatment of children with Crohn’s disease in Sweden: a questionnaire survey. Acta Paediatr. 2011;100(7):1018–22.PubMedCrossRefGoogle Scholar
  186. 186.
    Day AS, Stephenson T, Stewart M, Otley AR. Exclusive enteral nutrition for children with Crohn’s disease: use in Australia and attitudes of Australian paediatric gastroenterologists. J Paediatr Child Health. 2009;45(6):337–41.PubMedCrossRefGoogle Scholar
  187. 187.
    Stewart M, Day AS, Otley A. Physician attitudes and practices of enteral nutrition as primary treatment of paediatric Crohn disease in North America. J Pediatr Gastroenterol Nutr. 2009;52(1):38–42.CrossRefGoogle Scholar
  188. 188.
    Van Limbergen J, Haskett J, Griffiths AM, Critch J, Huynh H, Ahmed N, et al. Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablers. Can J Gastroenterol Hepatol. 2015;29(7):351–6.PubMedPubMedCentralCrossRefGoogle Scholar
  189. 189.
    Critch J, Day AS, Otley A, King-Moore C, Teitelbaum JE, Shashidhar H. Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2012;54(2):298–305.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Anthony R. Otley
    • 1
    • 2
  • Andrew S. Day
    • 3
    • 4
  • Mary Zachos
    • 5
    Email author
  1. 1.Faculty of MedicineDalhousie UniversityHalifaxCanada
  2. 2.Division of Gastroenterology & NutritionIWK Health CentreHalifaxCanada
  3. 3.Pediatric GastroenterologyChristchurch HospitalChristchurchNew Zealand
  4. 4.Department of PediatricsUniversity of OtagoChristchurchNew Zealand
  5. 5.Department of PediatricsMcMaster University, McMaster Children’s HospitalHamiltonCanada

Personalised recommendations